Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
38 hedge funds and large institutions have $110M invested in Flexion Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 8 closing their positions.
35% more capital invested
Capital invested by funds: $81.6M → $110M (+$28.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
10% less funds holding
Funds holding: 42 → 38 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$3.32M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$853K |
| 3 |
Jennison Associates
New York
|
+$581K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$434K |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$181K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$3.66M |
| 2 |
BC
Broadfin Capital
New York
|
-$724K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$552K |
| 4 |
SFM
Soros Fund Management
New York
|
-$405K |
| 5 |
SIM
Spark Investment Management
New York
|
-$136K |
FLXN Hedge Fund Activity: Q3 2014 in Review
38 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2014, worth a combined $110M — up 35% from $81.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FLXN and 4 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Capital World Investors, adding an estimated $3.32M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $3.66M sold.
- 38 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2014, down from 42 in Q2 2014.
- Funds reported $110M of Flexion Therapeutics, Inc. stock for Q3 2014, up 35% quarter-over-quarter.
- 4 funds opened new Flexion Therapeutics, Inc. positions in Q3 2014 and 8 closed out, a net change of -4 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2014 was Capital World Investors, an estimated $3.32M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2014 was JP Morgan Chase, an estimated $3.66M sold.
Based on aggregated 13F filings for Q3 2014.